子类别 會議論文/會議摘要 [2/2] 期刊論文 [22/23] 邻近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群统计 近3年内发表的文件:0(0.00%) 含全文笔数:24(96.00%) 文件下载次数统计 下载大于0次:24(100.00%) 下载大于100次:24(100.00%) 全文下载总次数:13172(0.25%) 最后更新时间: 2024-12-01 09:26 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Deacetylation of HSPA5 by HDAC6 lea... E1A-mediated inhibition of HSPA5 su... The STAT3-miRNA-92-Wnt signaling pa... Targeting the VEGF-C/VEGFR3 axis su... A novel application of E1A in combi... Vascular endothelial growth factor-... Dicer elicits paclitaxel chemosensi... NF-kappaB-driven suppression of FOX... Functional mechanism of hypoxia-ind... Triple-layer dissection of the lung...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目1-10 / 25. (共3页) 1 2 3 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2020-01	Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer [Erraturm: Oncogene. 2016 May;35(12):1517-1528.]	Oncogene. 2020 Jan;39(4):946-949.
2017-12	E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer [Erratum: Annals of Surgical Oncology. 2015;22(3):889-898.]	Annals of Surgical Oncology. 2017 Dec;24(Suppl. 3):685-686.
2017-04	The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer	Cancer Research. 2017 Apr;77(8):1955-1967.
2017-01	Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling	Oncotarget. 2017 Jan;8(3):5603-5618.
2016-11	Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma	Hepatology. 2016Nov;64(5):1637-1651.
2016-09	A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer	Oncotarget. 2016 Sep;7(39):63924-63936.
2016-07	Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL	Cancer Research. 2016 Jul;76(13):3916-3928.
2016-04-18	NF-kappaB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance	Proceedings of the National Academy of Sciences of the United States of America. 2016 Apr 18;113(18):E2526-E2535.
2016-04	Vascular endothelial growth factor-C promotes EGFR-TKIs resistance and cancer stemness via SLUG of non-small cell lung cancer	Journal of Thoracic Oncology. 2016 Apr;11(4, Suppl.):S132-133.
2016-03	miR-520h is crucial for DAPK2 regulation and breast cancer progression	Oncogene. 2016 Mar 3;35(9):1134-1142.

显示项目1-10 / 25. (共3页) 1 2 3 > >> 每页显示[10|25|50]项目